Morselli Simone, Zavatti Laura, Ferrari Riccardo, Gatti Lorenzo, Micali Salvatore, Rabito Salvatore, Cindolo Luca, Ferrari Giovanni
Department of Urology, C.Ur.E.-Centro Urologico Europeo, Hesperia Hospital, 41125 Modena, Italy.
Department of Clinical and Experimental Medicine, University of Florence, 50121 Florence, Italy.
Medicina (Kaunas). 2024 Dec 1;60(12):1973. doi: 10.3390/medicina60121973.
To prove the feasibility of continuous spinal extraperitoneal robot-assisted laparoscopic radical prostatectomy (cseRALP) in order to expand the pool of eligible patients. : According to IDEAL guidelines, a consecutive cohort of patients who underwent cseRALP was enrolled. Pre-, intra-, and post-operative data were collected, with particular focus on safety and oncological outcomes. : A total of three patients underwent this technique, with no intra- or post-operative medical complications. Only a grade 1 Clavien-Dindo complication was reported, small urinary leakage treated with an indwelling catheter. Oncological and functional results at month 3 were satisfactory, with no recurrence and no stress incontinence. : cseRALP seems to be feasible and safe; further trials are mandatory.
为证明连续性经腹膜外机器人辅助腹腔镜根治性前列腺切除术(cseRALP)的可行性,以扩大符合条件的患者群体。:根据IDEAL指南,纳入一组连续接受cseRALP的患者。收集术前、术中和术后数据,特别关注安全性和肿瘤学结果。:共有3例患者接受了该技术,未发生术中或术后医疗并发症。仅报告了1例Clavien-Dindo 1级并发症,即留置导尿管治疗的轻度尿漏。3个月时的肿瘤学和功能结果令人满意,无复发且无压力性尿失禁。:cseRALP似乎可行且安全;必须进行进一步试验。